Search This Blog

Tuesday, July 21, 2020

ALX Oncology closes $186M IPO

ALX Oncology (NASDAQ:ALXO) has closed its IPO of ~9.8M common shares at $19 per share, including the full exercise of underwriters’ over-allotment.
Gross proceeds were $185.7M.

Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)